Results 261 to 270 of about 218,733 (303)
Some of the next articles are maybe not open access.

Impaired glucose tolerance and impaired fasting glucose.

American family physician, 2004
Impaired glucose tolerance and impaired fasting glucose form an intermediate stage in the natural history of diabetes mellitus. From 10 to 15 percent of adults in the United States have one of these conditions. Impaired glucose tolerance is defined as two-hour glucose levels of 140 to 199 mg per dL (7.8 to 11.0 mmol) on the 75-g oral glucose tolerance ...
Shobha S, Rao   +2 more
openaire   +1 more source

Diabetes and impaired glucose tolerance prevalences in Turkish patients with impaired fasting glucose

Acta Diabetologica, 2008
Impaired fasting glucose (IFG) like impaired glucose tolerance (IGT) has increased risk of progressing to diabetes mellitus (DM). The aim of the study was to evaluate prevalance of IGT and type 2 DM with oral glucose tolerance test (OGTT) in Turkish patients who had fasting glucose of 110 and 125 mg/dl.
Tutuncuoglu P.   +5 more
openaire   +3 more sources

Different levels of thyroid hormones between impaired fasting glucose and impaired glucose tolerance: free T3 affects the prevalence of impaired fasting glucose and impaired glucose tolerance in opposite ways

Clinical Endocrinology, 2014
AbstractContextThere is an association between thyroid disorders and diabetes mellitus.ObjectiveTo investigate thyroid hormone levels in different glucose metabolic statuses, analyse relationships between thyroid hormone levels and different categories of prediabetes and metabolic parameters within a large euthyroid nondiabetic population.MethodsA ...
Su, Jing   +9 more
openaire   +2 more sources

Effects of n‐3 pufas on fasting plasma glucose and insulin resistance in patients with impaired fasting glucose or impaired glucose tolerance

BioFactors, 2016
AbstractAim: to evaluate if a supplementation with n‐3 PUFAs at high doses could give a regression of the condition of impaired glycemia. Methods: we enrolled 281 overweight/obese patients with impaired fasting glucose (IFG) or impaired glucose tolerance (IGT); 138 subjects were randomized to n‐3 PUFAs group, 1 g three times a day, and 143 to placebo ...
Derosa, G   +4 more
openaire   +4 more sources

EVALUATION OF CAROTIS INTIMA MEDIA THICKNESS IN IMPAIRED FASTING GLUCOSE AND IMPAIRED GLUCOSE TOLERANCE

Atherosclerosis Supplements, 2008
Increased carotid intima media thickness (CIMT) is recognized as the early indicator of atherosclerosis. We aimed to evaluate the effect of impaired fasting glucose (IFG) and impaired glucose tolerance (IGT) on the CIMT.We evaluated 51 dysglycemic patients (IFG [N.=22]; IGT [N.=29]) and 25 controls who have similar age and gender.
Y, Aydin   +7 more
openaire   +2 more sources

Impaired fasting glucose and impaired glucose tolerance in children and adolescents with overweight/obesity

Journal of Endocrinological Investigation, 2016
To investigate in a large sample of overweight/obese (OW/OB) children and adolescents the prevalence of prediabetic phenotypes such as impaired fasting glucose (IFG) and impaired glucose tolerance (IGT), and to assess their association with cardiometabolic risk (CMR) factors including hepatic steatosis (HS).Population data were obtained from the ...
Di Bonito, P.   +21 more
openaire   +5 more sources

Postprandial lipaemia in patients with impaired fasting glucose, impaired glucose tolerance and diabetes mellitus

Diabetes Research and Clinical Practice, 2008
To compare the postprandial lipid responses in subjects with prediabetes (IFG and IGT), newly detected diabetes mellitus (NDDM) and normal glucose tolerance (NGT).Postprandial lipid responses to a standard oral fat challenge was studied in forty-four subjects who were divided after an OGTT into NGT, pure impaired fasting glucose (PIFG), pure impaired ...
S V, Madhu   +5 more
openaire   +2 more sources

Pioglitazone for people with impaired glucose tolerance or impaired fasting blood glucose

2012
Reason for withdrawal from publication This review was withdrawn by the Editorial Office of the Cochrane Metabolic and Endocrine Disorders Group because authors could not commit adequate time to work on review drafts.
Li Cao   +5 more
openaire   +1 more source

Intermittent fasting in the prevention and treatment of cancer

Ca-A Cancer Journal for Clinicians, 2021
Katherine Clifton   +2 more
exaly  

Fasting impaired glucose and impaired glucose tolerance in a Mexican population

Diabetes Research and Clinical Practice, 2000
RuizG. Gloria   +4 more
openaire   +1 more source

Home - About - Disclaimer - Privacy